Your browser doesn't support javascript.
loading
Cytoplasmic HuR Status Predicts Disease-free Survival in Resected Pancreatic Cancer: A Post-hoc Analysis From the International Phase III ESPAC-3 Clinical Trial.
Tatarian, Talar; Jiang, Wei; Leiby, Benjamin E; Grigoli, Amanda; Jimbo, Masaya; Dabbish, Nooreen; Neoptolemos, John P; Greenhalf, William; Costello, Eithne; Ghaneh, Paula; Halloran, Christopher; Palmer, Daniel; Buchler, Markus; Yeo, Charles J; Winter, Jordan M; Brody, Jonathan R.
Afiliación
  • Tatarian T; Jefferson Pancreas, Biliary, and Related Cancer Center, Department of Surgery, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA.
  • Jiang W; Department of Pathology, Anatomy, and Cell Biology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA.
  • Leiby BE; Division of Biostatistics, Department of Pharmacology and Experimental Therapeutics, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA.
  • Grigoli A; Jefferson Pancreas, Biliary, and Related Cancer Center, Department of Surgery, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA.
  • Jimbo M; Jefferson Pancreas, Biliary, and Related Cancer Center, Department of Surgery, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA.
  • Dabbish N; Division of Biostatistics, Department of Pharmacology and Experimental Therapeutics, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA.
  • Neoptolemos JP; Institute of Translational Medicine, Cancer Research UK Liverpool Cancer Trials Unit, Liverpool, UK.
  • Greenhalf W; Institute of Translational Medicine, Cancer Research UK Liverpool Cancer Trials Unit, Liverpool, UK.
  • Costello E; Institute of Translational Medicine, Cancer Research UK Liverpool Cancer Trials Unit, Liverpool, UK.
  • Ghaneh P; Institute of Translational Medicine, Cancer Research UK Liverpool Cancer Trials Unit, Liverpool, UK.
  • Halloran C; Institute of Translational Medicine, Cancer Research UK Liverpool Cancer Trials Unit, Liverpool, UK.
  • Palmer D; Institute of Translational Medicine, Cancer Research UK Liverpool Cancer Trials Unit, Liverpool, UK.
  • Buchler M; Department of Surgery, University of Heidelberg, Heidelberg, Germany.
  • Yeo CJ; Jefferson Pancreas, Biliary, and Related Cancer Center, Department of Surgery, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA.
  • Winter JM; Jefferson Pancreas, Biliary, and Related Cancer Center, Department of Surgery, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA.
  • Brody JR; Jefferson Pancreas, Biliary, and Related Cancer Center, Department of Surgery, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA.
Ann Surg ; 267(2): 364-369, 2018 02.
Article en En | MEDLINE | ID: mdl-27893535
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Biomarcadores de Tumor / Carcinoma Ductal Pancreático / Desoxicitidina / Proteína 1 Similar a ELAV / Fluorouracilo / Antineoplásicos Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Surg Año: 2018 Tipo del documento: Article País de afiliación: Panamá
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Biomarcadores de Tumor / Carcinoma Ductal Pancreático / Desoxicitidina / Proteína 1 Similar a ELAV / Fluorouracilo / Antineoplásicos Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Surg Año: 2018 Tipo del documento: Article País de afiliación: Panamá